                         SEQUENCE LISTING

<110>  THE GOVERNMENT OF THE UNITED STATES FO AMERICA as represented by THE SECRETARY, 
DEPARTMENT OF HEALTH AND HUMAN SRVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION 
 
<120>  POLYPEPTIDE VACCINE AND VACCINATION STRATEGY AGAINST MYCOBACTERIUM


<130>  CDC-12752_38

<140>
<141> 2009-01-12

<150> US 61/020573
<151> 2008-01-11

<160>  6     

<170>  PatentIn version 3.5

<210>  1
<211>  29
<212>  DNA
<213>  Artificial Sequence


<220>
<223>  PCR forward primer for Rv0164 (mtsp-17/ TB18.5)

<400>  1
GCT CAT ATG ATG ACG GCA ATC TCG TGC TC

<210>  2
<211>  35
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  PCR reverse primer for Rv0164 (mtsp-17/ TB18.5)



<400>  2
GCT GGA TCC TTA GCT GGC CGC CAG CTG CTC GGC GC

<210>  3
<211>  28
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  PCR forward primer for Rv0831c (cfp-31)

<400>  3
GCT CAT ATG CTC CCC GAG ACA AAT CAG G

<210>  4
<211>  29
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  PCR reverse primer for Rv0831c (cfp-31)

<400>  4
GCT GGA TCC TTA CTG GCG AAG CAG CTC AT

<210>  5
<211>  28
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  PCR forward primer for Rv1324 (cfp-32) 

<400>  5
GCT CAT ATG ACG CGT CCG CGA CCC CCG C

<210>  6
<211>  30
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  PCR reverse primer for Rv1324 (cfp-32) 


<400>  6
GCT GGA TCC TCA GTA CAG CGC GTT GGC GAG